Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Could a daily dose of lutein boost kids' brainpower?

NCT ID NCT05177679

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 27, 2026 · Last updated Jul 28, 2026 · Updated 1 time

Summary

This trial tests whether giving children aged 8–10 a daily supplement of lutein and zeaxanthin — nutrients found in leafy greens and eggs — can improve their attention, memory, and academic achievement over a school year. Half the children receive the supplement, while the other half receive a placebo. Researchers will measure changes in cognitive tasks, school test scores, and a marker of eye health called macular pigment optical density.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a daily supplement containing 10 mg lutein and 2 mg zeaxanthin
What this could lead to
If it works, this could point toward a simple dietary supplement to help sharpen attention, memory, and academic performance in school-age children.
What could go wrong
This is a relatively small, early-stage trial in healthy children, so results may not apply broadly. The supplement is generally safe, but any cognitive benefits may be modest or absent.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

113 people

The number who actually took part.

Started

Jun 2022

Finished

Jul 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

8 to 10 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Child assent and parent/guardian consent * 8-10 years of age * No lutein supplementation within 6-months prior to enrollment (exception of multivitamins containing less than 1 mg lutein/day) * Absence of learning disability (parent-reported) * Tanner scale score ≤ 2 * 20/20 or corrected vision Exclusion Criteria: * Non-assent of child or non-consent of guardian * Above/below 8-10 years of age * Lutein supplementation within 6-months prior to enrollment (including multivitamins containing more than 1 mg lutein/day) * Identified learning disability (parent-reported) * Tanner scale score \> 2 * Not 20/20 or uncorrected vision

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Achievement are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • University of Illinois Urbana-Champaign

    Urbana, Illinois, 61801, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.